ישראל - עברית - Ministry of Health

medison pharma ltd - arsenic trioxide - תמיסה להזרקה - arsenic trioxide 1 mg/ml - arsenic trioxide - arsenic trioxide - induction of remission and consolidation in patients with acute promyelocytic leukemia (apl) who are refractory to or have relapsed from retinoid and anthracycline chemotherapy, and whose apl is characterized by the presence of the translocation of pml/rar-alpha gene expression.

ישראל - עברית - Ministry of Health

unipharm ltd, israel - pravastatin sodium - טבליה - pravastatin sodium 20 mg - pravastatin

ישראל - עברית - Ministry of Health

sanofi israel ltd - avalglucosidase alpha - אבקה להכנת תמיסה מרוכזת לעירוי - avalglucosidase alpha 100 mg/vial - avalglucosidase alpha

ישראל - עברית - Ministry of Health

eliezer linevitz ltd. - butorphanol as tartrate - תמיסה להזרקה - butorphanol as tartrate 10 mg / 1 ml

ישראל - עברית - Ministry of Health

mbi pharma ltd., israel - chenodeoxycholic acid - קפסולה קשיחה - chenodeoxycholic acid 250 mg - chenodeoxycholic acid

ישראל - עברית - Ministry of Health

unipharm ltd, israel - cilazapril - טבליה - cilazapril 2.5 mg - cilazapril - cilazapril - a blood pressure lowering agent. chronic heart failure.

ישראל - עברית - Ministry of Health

unipharm ltd, israel - cilazapril - טבליה - cilazapril 5 mg - cilazapril - cilazapril - a blood pressure lowering agent. chronic heart failure.

ישראל - עברית - Ministry of Health

unipharm ltd, israel - cilazapril; hydrochlorothiazide - טבליה - cilazapril 5 mg; hydrochlorothiazide 12.5 mg - cilazapril - cilazapril - treatment of essential hypertension in patients who have been stabilized on the individual components given in the same proportions.

ישראל - עברית - Ministry of Health

unipharm ltd, israel - cilazapril - טבליה - cilazapril 1 mg - cilazapril - cilazapril - a blood pressure lowering agent.chronic heart failure.

ישראל - עברית - Ministry of Health

unipharm ltd, israel - atorvastatin as calcium trihydrate salt - טבליה - atorvastatin as calcium trihydrate salt 10 mg - atorvastatin - atorvastatin - torid is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. torid is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190 mg/